Hormone and immune system interactions in demyelinating disease

Hormones and Behavior

Volumn 63, Issue 2, 2013, Pages 315-321

  Gomez, Francisco P ^a   Steelman, Andrew J ^a   Young, Colin R ^a   Welsh, C Jane ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

EAE; Estradiol; Estriol; Multiple sclerosis; Sex hormones; Theiler's virus

Indexed keywords

ESTRADIOL; ESTRIOL; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; SEX HORMONE;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; CARDIOVIRUS INFECTION; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL (TOPIC); DEGENERATIVE DISEASE; DEMYELINATING DISEASE; DISEASE COURSE; DRUG RECEPTOR BINDING; EPSTEIN BARR VIRUS INFECTION; GENDER BIAS; HIGH RISK POPULATION; HORMONAL REGULATION; HORMONAL THERAPY; HORMONE METABOLISM; HUMAN; IMMUNE SYSTEM; MORBIDITY; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NEUROENDOCRINE SYSTEM; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; POLARIZATION; PREGNANCY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SEX DIFFERENCE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; CELL COMMUNICATION; DISEASE MODELS, ANIMAL; ENDOCRINE SYSTEM; FEMALE; GONADAL STEROID HORMONES; HUMANS; IMMUNE SYSTEM; MALE; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; NEUROSECRETORY SYSTEMS;

EID: 84872869616     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2012.10.014     Document Type: Review

References (99)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature 1996, 383:787-793.
2. Abramsky O. Pregnancy and multiple sclerosis. Ann. Neurol. 1994, 36:S38-S41.
3. Acheson E.D. Epidemiology of multiple sclerosis. Br. Med. Bull. 1977, 33:9-14.
4. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 2003, 278:1910-1914.
5. Allen I., Brankin B.J. Pathogenesis of multiple sclerosis-the immune diathesis and the role of viruses. J. Neuropathol. Exp. Neurol. 1993, 52:95.
6. Alley J., Khasabov S., Simone D., Beitz A., Rodriguez M., Njenga M.K. More severe neurologic deficits in SJL/J male than female mice following Theiler's virus-induced CNS demyelination. Exp. Neurol. 2003, 180:14-24.
7. Alonso A., Jick S., Olek M.J., Ascherio A., Jick H., Hernan M.A. Recent use of oral contraceptives and the risk of multiple sclerosis. Arch. Neurol. 2005, 62:1362-1365.
8. Anderson D.W., Ellenberg J.H., Leventhal C.M., Reingold S.C., Rodriguez M., Silberberg D.H. Revised estimate of the prevalence of multiple sclerosis in the United States. Ann. Neurol. 1992, 31:333-336.
9. Bebo B.F., Vandenbark A.A., Offner H. Male SJL mice do not replace after induction of EAE with PLP 139-151. J. Neurosci. Res. 1996, 45:680-689.
10. Bebo B.F., Schuster J.C., Vandenbark A.A., Offner H. Gender differences in experimental autoimmune encephalomyelitis develop during the induction of the immune response to encephalitogenic peptides. J. Neurosci. Res. 1998, 52:420-426.
11. Bebo B.F., Adlard K., Schuster J.C., Unsicker L., Vandenbark A.A., Offner H. Gender differences in protection from EAE induced by oral tolerance with a peptide analogue of MBP-Ac1-11. J. Neurosci. Res. 1999, 55:432-440.
12. Bebo B.F., Fyfe-Johnson A., Adlard K., Beam A.G., Vandenbark A.A., Offner H. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J. Immunol. 2001, 166:2080-2089.
13. Beeson P.B. Age and sex associations of 40 autoimmune diseases. Am. J. Med. 1994, 96:457-462.
14. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
15. Challoner P.B., Smith K.T., Parker J.D., et al. Plaque-associated expression of human herpes virus 6 in multiple sclerosis. PNAS 1995, 92:7440-7444.
16. Chen H., Liu J., Yang M. Corticosteroids for Viral Myocarditis. Cochrane Database Syst. Rev. 2006, CD004471. (Review).
17. Chesik D., De Kesyer J. Progesterone and dexamethasone differentially regulate the IGF-system in glial cells. Neurosci. Lett. 2010, 468:178-182.
18. Cipolla M., Godfrey J., Wiegman M. The effect of ovariectomy and estrogen on penetrating brain arterioles and blood-brain barrier permeability. Microcirculation 2009, 16:685-693.
19. Compston A., Coles A. Multiple sclerosis. Lancet 2002, 359:1221-1231.
20. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. N. Engl. J. Med. 1998, 339:285-291.
21. Cottrell D.A., Kremenchutzky M., Rice G.P.A., Koopman W.J., Hader W., Bakerville J., Ebers G.C. The natural history of multiple sclerosis: a geographically based study 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 1999, 122:625-639.
22. Crawford D.K., Mangiardi M., Song B., Patel R., Du S., Sofroniew M.V., Voskhul R.R., Tiwari-Woodruff S.K. Estrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination. Brain 2010, 133:2999-3016.
23. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Zurawski S., Wiekowski M., Lira S.A., Gorman D., Kastelein R.A., Sedgwick J.D. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
24. Dal Canto M.C., Rabinowitz S.G. Experimental models of virus-induced demyelination of the central nervous system. Ann. Neurol. 1982, 11:109-127.
25. Fuller A., Yahikozawa H., So E.Y., Dal Canto M., Koh C.S., Welsh C.J., Kim B.S. Castration of male C57L/J mice increases susceptibility and estrogen treatment restores resistance to Theiler's virus-induced demyelinating disease. J. Neurosci. Res. 2007, 85:871-881.
26. Garay L., Deniselle M.C.G., Lima A., Roig P., De Nicola A.F. Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis. J. Steroid. Biochem. Mol. Biol. 2007, 107:228-237.
27. Giraud S.N., Caron C.M., Pham-Dinh D., Kitabgi P., Nicot A.B. Estradiol inhibits ongoing autoimmune neuroinflammation and NFkB-dependent CCL2 expression in reactive astrocytes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:8416-8421.
28. Gold S.M., Voskuhl R.R. Estrogen and testosterone therapies in multiple sclerosis. Progress in Brain Research 2009, 239-251. Elsevier, New York. J. Verhaagen, E.M. Hol, I. Huitenga, J. Wijnholds, A.B. Bergen, G.J. Boer, F.S. Dick (Eds.).
29. Goldman Consensus Group The Goldman consensus statement on depression in multiple sclerosis. Mult. Scler. 2005, 11:328-337.
30. Happel K.I., Dubin P.J., Zheng M., Ghilardi N., Lockhart C., Quinton L.J., Odden A.R., Shellito J.E., Bagby G.J., Nelson S., Kolls J.K. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 2005, 202:761-769.
31. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
32. Hernan M.A., Zhang S.M., Lipworth L., Olek M.J., Ascherio A. Multiple sclerosis and age at infection with common viruses. Epidemiology 2001, 12:301-306.
33. Hill K.E., Pigmans M., Fujinami R.S., Rose J.W. Gender variations in early Theiler's virus induced demyelinating disease: differential susceptibility and effects of IL-4, IL-10 and combined IL-4 with IL-10. J. Neuroimmunol. 1998, 85:44-51.
34. + T helper cells. Cell 2006, 126:1121-1133.
35. Kantarci O.H., Weinshenker B.G. Natural history of multiple sclerosis. Neurol. Clin. 2005, 23:17-38.
36. Kawaguchi M., Adachi M., Kokubu O.N., Huang S.K. IL-17 cytokine family. J. Allergy Clin. Immunol. 2004, 114:1265-1273.
37. Kim J.M., Rasmussen J.P., Rudensky A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nature Immunol. 2007, 8:191-197.
38. Kipp M., Beyer C. Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis. Front. Neuroendocrinol. 2009, 30:188-200.
39. Kipp M., Berger K., Clarner T., Dang K., Beyer C. Sex steroids control neuroinflammatory processes in the brain: relevance for acute ischemic and degenerative demyelination. J. Neuroendocrinol. 2012, 24:62-70.
40. Kobelt G., Atherly D., Hadjimichael O. Cost and quality of life in multiple sclerosis. Neurology 2006, 66:1696-1702.
41. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:566-573.
42. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., Fouser L.A. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 2006, 203:2271-2279.
43. Lipton H.L. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect. Immun. 1975, 11:1147.
44. Lipton H.L., Melvold R. Genetic analysis of susceptibility to Theiler's virus induced demyelinating disease in mice. J. Immunol. 1984, 116:125-135.
45. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesion: implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47:707-717.
46. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., Weaver C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
47. McClain M.A., Gatson N.N., Powell N.D., Papenfuss T.L., Gienapp I.E., Song F., Shawler T.M., Kithcart A., Whitacre C.C. Pregnancy suppresses experimental autoimmune encephalomyelitis through immunoregulatory cytokine production. J. Immunol. 2007, 179:8146-8152.
48. Morales L.B.J., Loo K.K., Liu H., Peterson C., Tiwari-Woodruff S., Voskuhl R.R. Treatment with an estrogen receptor-a ligand is neuroprotective in experimental autoimmune encephalomyelitis. Neurobiol. Dis. 2006, 26:6823-6833.
49. Nicot A. Gender and sex hormones in multiple sclerosis pathology and therapy. Front. Biosci. 2009, 14:4477-4515.
50. Noonan C.W., Kathman S.J., White M.C. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 2002, 58(1):136-138.
51. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 2000, 343:938-952.
52. Offner H., Polanczyk M. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis. Ann. N. Y. Acad. Sci. 2006, 1089:343-372.
53. Okuda Y., Okuda M., Bernard C.C. Gender does not influence the susceptibility of C57Bl/6 mice to develop chronic experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein. Immunol. Lett. 2002, 81:25-29.
54. Orton S.M., Herrera B.M., Yee I.M., Valdar W., Ramagopalan S.V., Sadovnick A.D., Ebers G.C. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 2006, 5:932-936.
55. Palaszynski K.M., Liu H., Loo K.K., Voskuhl R.R. Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J. Neuroimmunol. 2004, 149:84-89.
56. Palaszynski K.M., Loo K.K., Ashouri J.F., Liu H., Voskuhl R.R. Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J. Neuroimmunol. 2004, 146:144-152.
57. Papenfuss T.L., Roger C.J., Glenapp I., Yurris M., McClain M., Damico N., Valo J., Song F., Whitacre C.C. Sex differences on experimental autoimmune encephalomyelitis in multiple mouse strains. J. Neuroimmunol. 2004, 150:59-69.
58. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
59. Polanczyk M.J., Hopke C., Huan J., Vandenbark A.A., Offner H. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J. Neuroimmunol. 2005, 170:85-92.
60. Rangachari M., Nauermann N., Marty R.R., Dirnhofer S., Kurrer M.O., Komnenovic V., Penninger J.M., Eriksson U. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J. Exp. Med. 2006, 203:2009-2019.
61. Rinta S., Airas L., Elovaara I. Is the modulatory effect of pregnancy in multiple sclerosis associated with changes in blood apoptotic molecules?. Acta Neurol. Scand. 2010, 122:168-174.
62. Rodriguez M., David C.S. Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J. Immunol. 1985, 157:5699-5709.
63. Selvamani A., Sohrabji F. Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats. Neurobiol. Aging 2010, 31:1618-1628.
64. Serafini B., Rosicarelli B., Franciotta D., Magliozzi R., Reynolds R., Cinque P., Andreoni L., Trivedi P., Salvetti M., Faggioni A., Aloisi F. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 2007, 204:2899-2912.
65. Shaikh A.A. Estrone and estradiol levels in the ovarian venous blood from rats during the estrous cycle and pregnancy. Biol. Reprod. 1971, 5:297-307.
66. Sibley W.A., Bamford C.R., Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985, 1:1313.
67. Sicotte N.L., Liva S.M., Klutch R., et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann. Neurol. 2002, 52:421-428.
68. Sieve A.N., Steelman A.J., Young C.R., Storts R., Welsh T.H., Welsh C.J.R., Meagher M.W. Chronic restraint stress during early Theiler's virus infection exacerbates the subsequent demyelinating disease in SJL mice. J. Neuroimmunol. 2004, 155:103-118.
69. Smith R., Studd J.W. A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J. R. Soc. Med. 1992, 85:612-613.
70. Smith-Bouvier D.L., Divekar A.A., Sasidhar M., Du S., Tiwari-Woodruff S.K., King J.K., Arnold A.P., Singh R.R., Voskuhl R.R. A role for sex chromosome complement in the female bias in autoimmune disease. J. Exp. Med. 2008, 205:1099-1108.
71. Soldan S., Alvarez Retuerto A., Sicotte N., Voskuhl R. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J. Immunol. 2003, 171:6267-6274.
72. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
73. Spence R.D., Voskuhl R.R. Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Front. Neuroendocrinol. 2012, 33:105-115.
74. Spence R.D., Hamby M.E., Umeda E., Itoh N., Du S., Wisdom A.J., Cao Y., Bondar G., Lam J., Ao Y., Sandoval F., Suriany S., Sofroniew M.V., Voskuhl R.R. Neuroprotection mediated through estrogen receptor-α in astrocytes. Proc. Natl. Acad. Sci. 2011, 108:8867-8872.
75. Srivastava R., Aslam M., Kalluri S.R., Schirmer L., Buck D., Tackenberg B., Rothhammer V., Chan A., Gold R., Berthele A., Bennett J.L., Korn T., Hemmer B. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N. Engl. J. Med. 2012, 367:115-123.
76. Stuart M., Bergstrom L. Pregnancy and multiple sclerosis. J. Midwifery Womens Health 2011, 56:41-47.
77. Sutton C., Brereton C., Keogh B., Mills K.H.G., Lavelle E.C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 2006, 203:1685-1691.
78. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100:655-669.
79. Theiler M. Spontaneous encephalomyelitis of mice - a new virus. Science 1934, 80:122.
80. Thompson C., Powrie F. Regulatory T cells. Curr. Opin. Pharmacol. 2004, 4:408-414. (Review).
81. Tiwari-Woodruff S., Voskuhl R. Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice. J. Neurol. Sci. 2009, 286:81-85.
82. Tiwari-Woodruff S., Morales L.B.J., Lee R., Voskuhl R.R. Differential neuroprotective and antiflammatory effects of estrogen receptor (ER) alpha and ER beta ligand treatment. PNAS 2007, 104:14813-14818.
83. Vaknin-Dembinsky A., Balashov K., Weiner H.L. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J. Immunol. 2006, 176:7768-7774.
84. Valor L., Teijeiro R., Aristimuño C., Faure F., Alonso B., de Andres C., Tejera M., Lopez-Lazareno N., Fernandez-Cruz E., Sanchez-Ramon S. Estradiol-dependent perforin expression by human regulatory T-cells. Eur. J. Clin. Invest. 2011, 41:357-364.
85. Vegeto E., Benedusi V., Maggi A. Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Front. Neuroendocrinol. 2008, 29:507-519.
86. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGF-beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
87. Viglietta V., Baechder-Allan C., Weiner H.L., Hafler D.A. Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004, 199:1285-1291.
88. Voskuhl R. Hormone-based therapies in MS. Int. MS. J. 2003, 10:60-66.
89. Voskuhl R.R., Palaszynski K. Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 2001, 7:258-270.
90. Voskuhl R.R., Pitchekian-Halabi H., MacKenzie-Graham A., McFarland H.F., Raine C.S. Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Ann. Neurol. 1996, 39:724-733.
91. Weinshenker B.G. Natural history of multiple sclerosis. Ann. Neurol. 1994, 36(Suppl.):S6-S11.
92. Weinshenker B.G., Bass B., Rice G.P., Noseworthy J., Carriere W., Baskerville J., Ebers G.C. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989, 112:133-146.
93. Welsh C.J.R., Tonks P., Borrow P., Nash A.A. Theiler's virus: an experimental model of virus-induced demyelination. Autoimmunity 1990, 6:105-112.
94. Whitacre C.C. Sex differences in autoimmune disease. Nat. Immunol. 2001, 2:777-780.
95. Wingerchuk D.M., Lucchinetti C.F., Noseworthy J.H. Multiple sclerosis: current pathophysiological concepts. Lab. Invest. 2001, 81:263-281.
96. Witowski J., Ksiazek K., Jorres A. Interleukin-17: a mediator of inflammatory responses. Cell. Mol. Life Sci. 2004, 61:567-579.
97. Yates M.A., Li Y., Chlebeck P., Proctor T., Vandenbark A.A., Offner H. Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2010, 220:136-139.
98. Young E.E., Sieve A.N., Vichaya E.G., Carcoba L.M., Young C.R., Ambrus A., Storts R., Welsh C.J.R., Meagher M.W. Chronic restraint stress during early Theiler's virus infection exacerbates the subsequent demyelinating disease in SJL mice: II. CNS disease severity. J. Neuroimmunol. 2010, 220:79-89.
99. Zheng W., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine expression in CD4 T cells. Cell 1997, 89:587-596.